Carilex Medical, Inc.

7726 · TWO · Healthcare / Medical Devices

32.15TWD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close32.15

Open32.15

Day Range32.15 – 32.15

52-Week Range30.70 – 42.00

Volume15

Market Cap651.76M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.62

Dividend Yield0.00%

50-Day Avg32.06

200-Day Avg34.99

About

Carilex Medical, Inc. engages in the research and development, manufacture, and sale of medical devices for wound care management worldwide. It offers support surfaces, chair cushions, and negative pressure wound therapy products to prevent and manage pressure sores and wounds. The company was founded in 1985 and is headquartered in Taoyuan City, Taiwan.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Zhiwei Wang
HeadquartersNo.77, Keji 1st Road, Taoyuan City, Taiwan, 33383, Taiwan
Websitehttps://www.carilexmedical.com

Leadership

Mr. Zhiwei WangGeneral Manager
Ms. Soumi PanAccounting Manager

Financials

Income Statement

Currency: TWD	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	347.40M	387.75M	335.31M	466.36M	351.72M	338.63M
Growth (%)	-	+11.61%	-13.52%	+39.08%	-24.58%	-3.72%
Cost of Revenue	193.12M	219.15M	192.68M	269.62M	201.27M	239.51M
Gross Profit	154.29M	168.60M	142.63M	196.74M	150.45M	99.11M
Gross Margin	44.41%	43.48%	42.54%	42.19%	42.78%	29.27%
Operating Expense	81.32M	116.35M	125.06M	141.36M	147.43M	141.88M
Operating Income	72.97M	52.25M	17.57M	55.38M	3.03M	-42.76M
Operating Margin	21.00%	13.47%	5.24%	11.88%	0.86%	-12.63%
EBITDA	85.18M	59.56M	56.16M	78.84M	42.73M	-5.43M
EBITDA Margin	24.52%	15.36%	16.75%	16.91%	12.15%	-1.60%
Net Income	53.11M	32.34M	28.86M	44.44M	13.48M	-28.98M
Net Income Margin	15.29%	8.34%	8.61%	9.53%	3.83%	-8.56%
R&D	13.50M	29.88M	13.23M	18.63M	23.08M	23.11M
R&D as % of Total Revenue	3.89%	7.71%	3.95%	3.99%	6.56%	6.82%
Interest Expense	1.32M	1.08M	1.36M	1.70M	1.51M	2.51M
Interest Expense % of Total Revenue	0.38%	0.28%	0.40%	0.36%	0.43%	0.74%

Balance Sheet

Currency: TWD	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	354.46M	416.61M	414.73M	543.44M	459.63M	533.96M
Total Liabilities	138.58M	213.05M	177.55M	191.97M	129.59M	243.02M
Total Equity	215.88M	203.56M	237.18M	351.48M	330.04M	290.93M
Cash	105.05M	138.94M	129.41M	173.16M	137.10M	224.27M
Total Debt	85.85M	98.87M	102.22M	72.41M	71.87M	-
Net Debt	-19.19M	-40.06M	-27.19M	-100.75M	-65.23M	-

Cash Flow

Currency: TWD	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	45.81M	78.81M	33.21M	1.96M	24.97M	46.57M
Investing Cash Flow	-5.75M	-4.28M	-27.38M	-3.52M	-4.85M	-
Financing Cash Flow	-13.55M	-42.02M	-14.56M	47.50M	-52.69M	-
Capital Expenditure	1.53M	1.56M	28.18M	6.67M	2.92M	10.52M
Free Cash Flow	44.28M	77.24M	4.86M	-4.70M	22.05M	36.04M
Dividends Paid	-	48.42M	-	-	35.94M	11.57M
FCF to OCF	96.66%	98.02%	14.62%	-239.51%	88.29%	77.40%
Dividend Paid to FCF	-	62.68%	-	-	163.01%	32.11%

Key Statistics & Ratios

Market Cap651.76M

Enterprise Value574.20M

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.72

Price / Book2.20

EPS-0.62

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets0.00%

Shares Outstanding20.30M

Shares Float0

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%